1. Home
  2. NRXP vs LFWD Comparison

NRXP vs LFWD Comparison

Compare NRXP & LFWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • LFWD
  • Stock Information
  • Founded
  • NRXP 2015
  • LFWD 2001
  • Country
  • NRXP United States
  • LFWD Israel
  • Employees
  • NRXP N/A
  • LFWD N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • LFWD
  • Sector
  • NRXP Health Care
  • LFWD
  • Exchange
  • NRXP Nasdaq
  • LFWD NYSE
  • Market Cap
  • NRXP 48.5M
  • LFWD 13.7M
  • IPO Year
  • NRXP N/A
  • LFWD 2014
  • Fundamental
  • Price
  • NRXP $4.01
  • LFWD $1.64
  • Analyst Decision
  • NRXP Strong Buy
  • LFWD Strong Buy
  • Analyst Count
  • NRXP 3
  • LFWD 1
  • Target Price
  • NRXP $31.67
  • LFWD $13.00
  • AVG Volume (30 Days)
  • NRXP 2.8M
  • LFWD 683.8K
  • Earning Date
  • NRXP 11-14-2024
  • LFWD 02-25-2025
  • Dividend Yield
  • NRXP N/A
  • LFWD N/A
  • EPS Growth
  • NRXP N/A
  • LFWD N/A
  • EPS
  • NRXP N/A
  • LFWD N/A
  • Revenue
  • NRXP N/A
  • LFWD $25,002,000.00
  • Revenue This Year
  • NRXP N/A
  • LFWD $87.01
  • Revenue Next Year
  • NRXP N/A
  • LFWD $47.64
  • P/E Ratio
  • NRXP N/A
  • LFWD N/A
  • Revenue Growth
  • NRXP N/A
  • LFWD 173.28
  • 52 Week Low
  • NRXP $1.10
  • LFWD $1.41
  • 52 Week High
  • NRXP $7.33
  • LFWD $7.84
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 61.48
  • LFWD 45.37
  • Support Level
  • NRXP $3.20
  • LFWD $1.83
  • Resistance Level
  • NRXP $6.01
  • LFWD $4.00
  • Average True Range (ATR)
  • NRXP 0.95
  • LFWD 0.37
  • MACD
  • NRXP 0.11
  • LFWD -0.04
  • Stochastic Oscillator
  • NRXP 56.52
  • LFWD 7.45

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About LFWD REWALK ROBOTICS LTD

Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.

Share on Social Networks: